USAID and USP Expand Efforts to Combat Counterfeit Drug Sales
The statistics are staggering. According to the U.S.-based Center for Medicines in the Public Interest, counterfeit drug sales will reach $75 billion globally in 2010 –that’s an increase of more than 90 percent from 2005.
As you might expect, the threat of substandard and counterfeit medicines is particularly high in developing countries, where regulation is weakest, and that’s why I was pleased to hear that earlier this week the U.S. Agency for International Development (USAID) and the U.S. Pharmacopeial (USP) Convention announced that are launching a new program that will expand their joint efforts to combat counterfeit drug sales throughout the developing world.
(more…)
